The Promise of Neoadjuvant and Adjuvant Therapies for Renal Cancer

被引：12
|
作者：
Leow, Jeffrey J. [1 ]
Ray, Shagnik [2 ]
Dason, Shawn [2 ]
Singer, Eric A. [2 ]
Chang, Steven L. [3 ]
机构：
[1] Tan Tock Seng Hosp, Dept Urol, 11 Jalan Tan Tock Seng, Annex 1-L04 Uro, Singapore 308433, Singapore
[2] Ohio State Univ, Div Urol Oncol, Comprehens Canc Ctr, Olentangy River Rd,Suite 3100, Columbus, OH 43212 USA
[3] Brigham & Womens Hosp, Div Urol, 45 Francis St,Suite ASBII 3, Boston, MA 02115 USA
来源：
UROLOGIC CLINICS OF NORTH AMERICA | 2023年 / 50卷 / 02期
关键词：
Renal cancer; Kidney neoplasms; Radical nephrectomy; Systemic therapy; Neoadjuvant therapy; Adjuvant therapy; Immunotherapy; Targeted therapy; CAVA TUMOR THROMBUS; CELL CARCINOMA; HIGH-RISK; RADICAL NEPHRECTOMY; PHASE-III; STAGE-II; SURVIVAL; INTERLEUKIN-2; SUNITINIB; RECURRENCE;
D O I：
10.1016/j.ucl.2023.01.011
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：285 / 303
页数：19
相关论文
共 50 条
  • [21] Adjuvant and neoadjuvant cancer therapies: A historical review and a rational approach to understand outcomes
    Burotto, Mauricio
    Wilkerson, Julia
    Stein, Wilfred D.
    Bates, Susan E.
    Fojo, Tito
    SEMINARS IN ONCOLOGY, 2019, 46 (01) : 83 - 99
  • [22] DEMONSTRATING PAYER VALUE FOR ADJUVANT AND NEOADJUVANT THERAPIES
    O'Toole, G.
    Hinson, A.
    Ismailoglu, I.
    Hunt, M.
    VALUE IN HEALTH, 2020, 23 : S672 - S672
  • [23] Adjuvant and neoadjuvant therapies of pancreatic cancerA review
    Jules Harris
    Howard Bruckner
    International Journal of Pancreatology, 2001, 29 : 1 - 7
  • [24] Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials
    D'Angelo, Francesco A.
    Antolino, Laura
    La Rocca, Mara
    Petrucciani, Niccolo
    Magistri, Paolo
    Aurello, Paolo
    Ramacciato, Giovanni
    MEDICAL ONCOLOGY, 2016, 33 (03) : 1 - 9
  • [25] Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials
    Francesco A. D’Angelo
    Laura Antolino
    Mara La Rocca
    Niccolò Petrucciani
    Paolo Magistri
    Paolo Aurello
    Giovanni Ramacciato
    Medical Oncology, 2016, 33
  • [26] Neoadjuvant and adjuvant multimodality therapies in resectable esophagogastric adenocarcinoma
    Lau, David K.
    Athauda, Avani
    Chau, Ian
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (11) : 1429 - 1441
  • [27] Efficacy of Adjuvant and Neoadjuvant Therapies for Adult Orbital Sarcomas
    Savar, Aaron
    Trent, Jonathan
    Al-Zubidi, Nagham
    Huh, Winston
    Anderson, Pete
    Shinder, Roman
    Esmaeli, Bita
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2010, 26 (03): : 185 - 189
  • [28] Acute renal failure - The promise of new therapies
    Humes, HD
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (12): : 870 - 871
  • [29] Surgical management of locally advanced and metastatic renal cancer: neoadjuvant and adjuvant strategies
    Pignot, G.
    Drai, J.
    Patard, J. -J.
    MINERVA UROLOGICA E NEFROLOGICA, 2014, 66 (01) : 49 - 55
  • [30] Systemic Therapies for Nonmetastatic Breast Cancer: The Role of Neoadjuvant and Adjuvant Chemotherapy and the Use of Endocrine Therapy
    Bychkovsky, Brittany L.
    Dizon, Don S.
    Sikov, William M.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2016, 59 (04): : 756 - 771
12345